Lee WK - Search Results

1

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma.

Cho EK, Lee WK, Lim DY, Bang SM, Park DK, Park YH, Kwon OS, Choi DJ, Shin DB, Lee JH, Lee TH. Cho EK, et al. Among authors: lee wk, lee th, lee jh. J Korean Med Sci. 2002 Jun;17(3):348-52. doi: 10.3346/jkms.2002.17.3.348. J Korean Med Sci. 2002. PMID: 12068138 Free PMC article. Clinical Trial.

2

A phase II study of epirubicin, cisplatin and capecitabine combination chemotherapy in patients with metastatic or advanced gastric cancer.

Cho EK, Lee WK, Im SA, Lee SN, Park SH, Bang SM, Park DK, Park YH, Shin DB, Lee JH. Cho EK, et al. Among authors: lee wk, lee sn, lee jh. Oncology. 2005;68(4-6):333-40. doi: 10.1159/000086972. Epub 2005 Jul 11. Oncology. 2005. PMID: 16020960 Clinical Trial.

3

Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer.

Park SH, Bang SM, Cho EK, Shin DB, Lee JH, Lee WK, Chung M. Park SH, et al. Among authors: lee wk, lee jh. BMC Cancer. 2005 Jul 22;5:87. doi: 10.1186/1471-2407-5-87. BMC Cancer. 2005. PMID: 16042786 Free PMC article. Clinical Trial.

4

A pilot study of cisplatin, irinotecan, leucovorin and 5-fluorouracil (PILF) combination chemotherapy for advanced gastric cancer.

Park SH, Jeon SY, Ko KI, Nam E, Bang SM, Cho EK, Shin DB, Lee JH, Lee WK, Chung M. Park SH, et al. Among authors: lee wk, lee jh. Cancer Res Treat. 2006;38(3):121-5. doi: 10.4143/crt.2006.38.3.121. Epub 2006 Jun 30. Cancer Res Treat. 2006. PMID: 19771271 Free PMC article.

5

Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer.

Sym SJ, Hong J, Jung M, Park J, Cho EK, Lee WK, Chung M, Kim HS, Lee JH, Shin DB. Sym SJ, et al. Among authors: lee wk, lee jh. Cancer Chemother Pharmacol. 2012 Aug;70(2):277-84. doi: 10.1007/s00280-012-1912-0. Epub 2012 Jun 30. Cancer Chemother Pharmacol. 2012. PMID: 22752217 Clinical Trial.

6

A randomized phase II study of biweekly irinotecan monotherapy or a combination of irinotecan plus 5-fluorouracil/leucovorin (mFOLFIRI) in patients with metastatic gastric adenocarcinoma refractory to or progressive after first-line chemotherapy.

Sym SJ, Hong J, Park J, Cho EK, Lee JH, Park YH, Lee WK, Chung M, Kim HS, Park SH, Shin DB. Sym SJ, et al. Among authors: lee wk, lee jh. Cancer Chemother Pharmacol. 2013 Feb;71(2):481-8. doi: 10.1007/s00280-012-2027-3. Epub 2012 Nov 29. Cancer Chemother Pharmacol. 2013. PMID: 23192279 Clinical Trial.

7

A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.

Kim YS, Sym SJ, Park SH, Park I, Hong J, Ahn HK, Park J, Cho EK, Lee WK, Chung M, Lee JH, Shin DB. Kim YS, et al. Among authors: lee wk, lee jh. Cancer Chemother Pharmacol. 2014 Jan;73(1):163-9. doi: 10.1007/s00280-013-2334-3. Epub 2013 Nov 8. Cancer Chemother Pharmacol. 2014. PMID: 24202666 Clinical Trial.

8

Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy.

Park SH, Lee WK, Chung M, Bang SM, Cho EK, Lee JH, Shin DB. Park SH, et al. Among authors: lee wk, lee jh. Cancer Chemother Pharmacol. 2006 Feb;57(3):289-94. doi: 10.1007/s00280-005-0055-y. Epub 2005 Jul 12. Cancer Chemother Pharmacol. 2006. PMID: 16010588

9

Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study.

Kim YS, Sym SJ, Baek MY, Park I, Hong J, Ahn HK, Park J, Cho EK, Lee WK, Chung M, Kim HS, Lee JH, Shin DB. Kim YS, et al. Among authors: lee wk, lee jh. Cancer Chemother Pharmacol. 2015 Dec;76(6):1267-72. doi: 10.1007/s00280-015-2881-x. Epub 2015 Oct 19. Cancer Chemother Pharmacol. 2015. PMID: 26482716 Clinical Trial.

10

Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy.

Park JH, Yeo JH, Kim YS, Park I, Ahn HK, Shin DB, Lee WK, Yang JY, Kim HS, Sym SJ. Park JH, et al. Among authors: lee wk. Am J Clin Oncol. 2021 Jun 1;44(6):232-238. doi: 10.1097/COC.0000000000000810. Am J Clin Oncol. 2021. PMID: 33710139 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,665 results

Search Page